###begin article-title 0
Regulation of PERK Signaling and Leukemic Cell Survival by a Novel Cytosolic Isoform of the UPR Regulator GRP78/BiP
###end article-title 0
###begin p 1
Conceived and designed the experiments: MN HZ PB ASL. Performed the experiments: MN HZ SW PB. Analyzed the data: MN HZ SW PB ASL. Contributed reagents/materials/analysis tools: MN. Wrote the paper: MN ASL.
###end p 1
###begin p 2
###xml 1320 1323 1320 1323 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 824 829 <span type="species:ncbi:9606">human</span>
###xml 858 866 <span type="species:ncbi:9606">patients</span>
The unfolded protein response (UPR) is an evolutionarily conserved mechanism to allow cells to adapt to stress targeting the endoplasmic reticulum (ER). Induction of ER chaperone GRP78/BiP increases protein folding capacity; as such it represents a major survival arm of UPR. Considering the central importance of the UPR in regulating cell survival and death, evidence is emerging that cells evolve feedback regulatory pathways to modulate the key UPR executors, however, the precise mechanisms remain to be elucidated. Here, we report the fortuitous discovery of GRP78va, a novel isoform of GRP78 generated by alternative splicing (retention of intron 1) and alternative translation initiation. Bioinformatic and biochemical analyses revealed that expression of GRP78va is enhanced by ER stress and is notably elevated in human leukemic cells and leukemia patients. In contrast to the canonical GRP78 which is primarily an ER lumenal protein, GRP78va is devoid of the ER signaling peptide and is cytosolic. Through specific knockdown of endogenous GRP78va by siRNA without affecting canonical GRP78, we showed that GRP78va promotes cell survival under ER stress. We further demonstrated that GRP78va has the ability to regulate PERK signaling and that GRP78va is able to interact with and antagonize PERK inhibitor P58IPK. Our study describes the discovery of GRP78va, a novel cytosolic isoform of GRP78/BiP, and the first characterization of the modulation of UPR signaling via alternative splicing of nuclear pre-mRNA. Our study further reveals a novel survival mechanism in leukemic cells and other cell types where GRP78va is expressed.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 460 463 460 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Rutkowski1">[1]</xref>
###xml 465 468 465 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Ron1">[2]</xref>
Major advances have been made during the past decade in the understanding of how cells respond to impairment or saturation of the protein maturation machinery of the endoplasmic reticulum (ER). The unfolded protein response (UPR) signaling pathways are activated to reduce the unfolded protein load and at the same time increase protein folding capacity. The initiation of UPR is primarily regulated by the ER-transmembrane sensor proteins PERK, IRE1 and ATF6 [1], [2]. Upon ER stress, PERK activation leads to phosphorylation of the eukaryotic translation initiation factor eIF2alpha, which inhibits global protein biosynthesis while activating the translation of the transcription factor ATF4. Along with activated ATF6 and IRE1/XBP-1, ATF4 activates transcription of ER chaperones and folding enzymes, thus improving the protein processing capacity and alleviating protein aggregation in the ER.
###end p 4
###begin p 5
###xml 137 140 137 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Lee1">[3]</xref>
###xml 141 144 141 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Li1">[5]</xref>
###xml 260 263 260 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Ting1">[6]</xref>
###xml 584 587 584 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Lee2">[7]</xref>
###xml 739 742 739 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-OkudaShimizu1">[8]</xref>
###xml 744 747 744 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Ushioda1">[9]</xref>
###xml 856 860 856 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Bertolotti1">[10]</xref>
###xml 862 866 862 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Zhou1">[11]</xref>
###xml 955 959 955 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Rao1">[12]</xref>
###xml 960 964 960 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Fu1">[14]</xref>
###xml 1281 1285 1281 1285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Lee3">[15]</xref>
###xml 1286 1290 1286 1290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Wang1">[17]</xref>
###xml 237 242 <span type="species:ncbi:9606">human</span>
###xml 247 252 <span type="species:ncbi:10090">mouse</span>
A major ER chaperone is the 78 kDa glucose regulated protein GRP78, also referred to as BiP (immunoglobulin heavy chain binding protein) [3]-[5]. GRP78 belongs to the HSP70 protein family and is encoded by a single copy gene in both the human and mouse genome [6]. In contrast to the cytosolic counterparts of the HSP70 protein family, the amino-terminus of GRP78 contains a signal peptide that targets it to the ER and its carboxy-terminus contains the ER retention signal motif KDEL. The induction of GRP78 has been widely used as a sentinel marker for ER stress and UPR activation [7]. As an ER resident protein, GRP78 facilitates protein assembly, prevents intermediates from aggregation and targets misfolded proteins for degradation [8], [9]. In non-stressed mammalian cells, GRP78 binds to PERK, IRE1 and ATF6 and maintains them in an inactive form [10], [11]. GRP78 also interacts with pro-apoptotic molecules at the ER, blocking their activation [12]-[14]. When unfolded proteins pull GRP78 away from them, these pathways are activated, triggering the UPR, and if the stress is too severe, apoptosis. Therefore, as a key UPR regulator and target, GRP78 is postulated to play pivotal roles in pathological processes, however, the precise mechanisms remain to be determined [15]-[17].
###end p 5
###begin p 6
###xml 80 83 80 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Rutkowski1">[1]</xref>
###xml 85 88 85 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Ron1">[2]</xref>
###xml 90 94 90 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Rutkowski2">[18]</xref>
###xml 96 100 96 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Lin1">[19]</xref>
###xml 281 284 281 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 370 374 366 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Lee4">[20]</xref>
###xml 379 382 375 378 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 574 578 570 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-vanHuizen1">[21]</xref>
###xml 661 664 657 660 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 742 746 738 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Oyadomari1">[22]</xref>
###xml 764 767 760 763 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 892 896 888 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Rutkowski3">[23]</xref>
Considering the central importance of UPR in regulating cell survival and death [1], [2], [18], [19], the prediction is that cells will evolve feedback regulatory pathways to modulate the key UPR executors. One such example is the ER stress induction of the DnaJ family protein P58IPK, first discovered as an inhibitor of the eIF2alpha protein kinase PKR in the cytosol [20]. P58IPK serves as a negative feedback of UPR signaling by binding to the cytosolic domain of PERK and inhibiting its kinase activity, thereby terminating PERK activation in the late phase of the UPR [21]. As part of a protein complex with HSP70 at the cytosolic face of translocons, P58IPK has been implicated as a mediator of co-translational ER protein degradation [22]. Nonetheless, P58IPK was recently determined to be an ER lumenal protein, where it acts as a co-chaperone of GRP78 in protecting the stressed ER [23].
###end p 6
###begin p 7
###xml 261 265 261 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Schwerk1">[24]</xref>
###xml 267 271 267 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Pajares1">[25]</xref>
###xml 312 317 312 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78</italic>
###xml 693 697 693 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Ast1">[26]</xref>
###xml 1192 1195 1192 1195 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 296 301 <span type="species:ncbi:9606">human</span>
###xml 306 311 <span type="species:ncbi:10090">mouse</span>
###xml 779 784 <span type="species:ncbi:9606">human</span>
###xml 891 899 <span type="species:ncbi:9606">patients</span>
Alternative splicing is increasingly recognized as a crucial mechanism for generating protein isoforms with distinct cellular localization and sometimes antagonistic roles regulating survival and apoptotic processes, impacting various diseases including cancer [24], [25]. We discovered that the human and mouse Grp78 allele contains conserved non-canonical splice sites and ER stress enhances the production of a variant form of GRP78 through retention of the first intron and internal translation initiation, referred to below as GRP78va. Among the various types of alternative pre-mRNA splicing, intron retention is relatively rare and few examples of biological consequence are documented [26]. Lacking the ER signal sequence, GRP78va is cytosolic and is notably elevated in human leukemic cell lines subjected to ER stress. The transcript of GRP78va is also present in AML, CML and ALL patients, but not in normal controls. GRP78va is a promoter of cell survival under ER stress. Through overexpression and siRNA knockdown studies, we further demonstrated that GRP78va has the ability to regulate PERK signaling and is able to interact with and act as an antagonist of PERK inhibitor P58IPK. Collectively, these studies provide the first evidence of the modulation of UPR signaling via alternative splicing of nuclear pre-mRNA and reveal a fundamentally new concept for a survival mechanism in leukemic cells and other cell types where GRP78va is expressed.
###end p 7
###begin title 8
Results
###end title 8
###begin title 9
###xml 46 51 46 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78</italic>
###xml 55 60 <span type="species:ncbi:10090">mouse</span>
###xml 65 70 <span type="species:ncbi:9606">human</span>
Identification of a novel splicing variant of Grp78 in mouse and human
###end title 9
###begin p 10
###xml 135 144 135 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g001">Figure 1A</xref>
###xml 273 278 273 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78</italic>
###xml 280 287 280 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 321 326 321 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78</italic>
###xml 442 452 442 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006868.s002">Figure S1A</xref>
###xml 611 621 611 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006868.s002">Figure S1B</xref>
###xml 724 734 724 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006868.s002">Figure S1B</xref>
###xml 899 904 899 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78</italic>
###xml 917 927 917 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006868.s002">Figure S1C</xref>
###xml 1154 1164 1154 1164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006868.s002">Figure S1D</xref>
###xml 1220 1225 1220 1225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78</italic>
###xml 1405 1410 1405 1410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78</italic>
###xml 1412 1423 1412 1423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g001">Figure 1A,B</xref>
###xml 159 164 <span type="species:ncbi:10090">mouse</span>
###xml 169 174 <span type="species:ncbi:9606">human</span>
###xml 893 898 <span type="species:ncbi:10090">mouse</span>
###xml 1399 1404 <span type="species:ncbi:10090">mouse</span>
GRP78 is a highly conserved ER chaperone protein. Critical domains include the ATPase catalytic domain and the peptide binding domain (Figure 1A). In both the mouse and human genome, GRP78 is encoded by a single-copy gene consisting of 8 exons. A novel splicing variant of Grp78 (Grp78va) was discovered during RT-PCR of Grp78 cDNA prepared from NIH3T3 cells, using primers spanning the 5' end of exon 1 (p1) and the exon 1/2 junction (p2a) (Figure S1A). To our surprise, two PCR bands were detected, with the additional upper band clearly evident in cells treated with the ER stress inducer thapsigargin (Tg) (Figure S1B). Amplification of genomic DNA was ruled out in control PCR reactions performed with RNA as template (Figure S1B). Sequencing of the RT-PCR products revealed that the novel upper band contains an additional 112 bp intron 1 sequence which was spliced out in the canonical mouse Grp78 transcript (Figure S1C). We determined that the fortuitous production of the novel PCR band could be due to the high sequence homology between the p2a primer complementary sequence at the exon 1/2 junction and the intron 1/exon 2 junction sequence (Figure S1D), which led to the amplification of both the canonical Grp78 and the intron 1 retention variant form. The initial PCR results using primers p1/p2a were confirmed by using another set of primers (p1/p2), with p2 flanking the exon 2 of mouse Grp78 (Figure 1A,B).
###end p 10
###begin title 11
###xml 49 56 49 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78</italic>
###xml 60 65 <span type="species:ncbi:10090">mouse</span>
Detection of the alternative splicing transcript Grp78va of mouse Grp78.
###end title 11
###begin p 12
###xml 67 73 67 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mGrp78</italic>
###xml 413 418 413 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78</italic>
###xml 564 571 564 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 628 635 628 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 915 922 912 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 995 1002 992 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 650 655 <span type="species:ncbi:10090">mouse</span>
###xml 943 948 <span type="species:ncbi:10090">mouse</span>
###xml 1023 1028 <span type="species:ncbi:10090">mouse</span>
###xml 1159 1164 <span type="species:ncbi:10090">mouse</span>
A. Schematic representation of GRP78 protein domains and canonical mGrp78 and alternative transcripts. KDEL refers to the ER retention signal. Arrows labeled as p1 to p5 indicate positions of the primers used in RT-PCR. The sequence of 5' splice site (5'ss) and 3' splice site (3'ss) of intron 1 are aligned with the optimal splice site sequences. The translational initiation codon (AUG) and stop codon (UAG) of Grp78 are located in exon 1 and exon 8 respectively. Intron 1 contains a stop codon UAA. The underlined AUG in exon 3 is a putative initiation site of Grp78va embedded in a consensus Kozak sequence. B. Detection of Grp78va transcript in mouse NIH3T3 cells by RT-PCR. NIH3T3 cells were either non-treated (-) or treated with 300 nM thapsigargin (Tg) for 16 hours and the total RNA were subjected to RT-PCR with the indicated primer sets. beta-actin levels served as control. C. RT-PCR identification of Grp78va transcript in E11.5 mouse embryos and indicated organs. D. Detection of Grp78va transcript in adult mouse tissues. Total RNA extracted from the spleen, kidney, liver, heart, intestine, lung, cerebral cortex and cerebellum of a 5 wk old mouse were subjected to RT-PCR with the indicated primer sets.
###end p 12
###begin p 13
###xml 168 175 168 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 247 256 247 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g001">Figure 1A</xref>
###xml 291 298 291 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 377 386 377 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g001">Figure 1C</xref>
###xml 426 433 426 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 592 601 592 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g001">Figure 1D</xref>
###xml 640 647 640 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 699 704 699 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78</italic>
###xml 332 337 <span type="species:ncbi:10090">mouse</span>
###xml 471 476 <span type="species:ncbi:10090">mouse</span>
To further investigate the intron-retention variant form and determine whether it is expressed beyond cells in culture, two primer pairs (p1/p3; p4/p5) specific to the Grp78va transcript were designed, with both p3 and p4 located within intron 1 (Figure 1A). RT-PCR analysis showed that the Grp78va transcript was detected in E11.5 mouse embryos and embryonic brain and heart (Figure 1C). Interestingly, in adult tissues, the Grp78va transcript was readily detectable in mouse spleen, kidney, liver and cerebellum, and below detection limit in the heart, intestine, lung and cerebral cortex (Figure 1D). In every case, expression levels of Grp78va transcript directly parallel that of the canonical Grp78.
###end p 13
###begin p 14
###xml 4 11 4 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 172 177 172 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78</italic>
###xml 188 197 188 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g002">Figure 2A</xref>
###xml 241 243 241 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 273 278 273 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78</italic>
###xml 309 316 309 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 374 385 374 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g002">Figure 2A,B</xref>
###xml 566 571 566 571 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78</italic>
###xml 571 574 571 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Lee1">[3]</xref>
###xml 607 614 607 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 616 625 616 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006868.s003">Figure S2</xref>
###xml 738 745 738 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 758 767 758 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g002">Figure 2B</xref>
###xml 783 788 783 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78</italic>
###xml 836 845 836 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g002">Figure 2C</xref>
###xml 877 884 877 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 1099 1104 1099 1104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78</italic>
###xml 57 62 <span type="species:ncbi:9606">human</span>
###xml 166 171 <span type="species:ncbi:9606">human</span>
###xml 818 823 <span type="species:ncbi:9606">human</span>
###xml 916 921 <span type="species:ncbi:9606">human</span>
###xml 960 965 <span type="species:ncbi:9606">human</span>
The Grp78va transcript was also detected in a variety of human monolayer and suspension cell lines, as determined by RT-PCR using primer pairs p1/p3 and p4/p5 of the human Grp78 sequence (Figure 2A). As expected, Tg, which depletes the ER Ca2+ store, induced the canonical Grp78 transcript, and the levels of Grp78va transcript were also increased in cells treated with Tg (Figure 2A,B). In addition, other ER stress inducers, the glycosylation inhibitor tunicamycin (Tun) and the proline acid analogue L-azetidine 2-carboxylic acid (AzC), known to induce canonical Grp78[3], also induced the expression of Grp78va (Figure S2). Utilizing quantitative real-time PCR, we further measured and compared the basal and Tg-induced levels of the Grp78va transcript (Figure 2B) and the total Grp78 transcript levels in various human cell lines (Figure 2C). Notably, high basal level of Grp78va transcript was detected in the human breast cancer cell line MCF-7 and the human acute promyelocytic leukemia (APL) cell line HL-60. Among all the cell lines tested, HL-60 also expressed the highest level of total Grp78 transcripts.
###end p 14
###begin title 15
###xml 22 29 22 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 44 49 <span type="species:ncbi:9606">human</span>
###xml 74 81 <span type="species:ncbi:9606">patient</span>
Identification of the Grp78va transcript in human cell lines and leukemia patient samples.
###end title 15
###begin p 16
###xml 21 28 21 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 269 276 269 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 286 295 286 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g001">Figure 1A</xref>
###xml 370 377 370 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 388 393 388 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78</italic>
###xml 464 471 464 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 725 730 722 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78</italic>
###xml 103 108 <span type="species:ncbi:9606">human</span>
###xml 249 254 <span type="species:ncbi:9606">human</span>
###xml 419 424 <span type="species:ncbi:9606">human</span>
###xml 506 514 <span type="species:ncbi:9606">patients</span>
###xml 584 592 <span type="species:ncbi:9606">patients</span>
###xml 645 652 <span type="species:ncbi:9606">patient</span>
###xml 823 831 <span type="species:ncbi:9606">patients</span>
A. Expression of the Grp78va transcript was determined by RT-PCR with the total RNA from the indicated human cell lines, which were either non-treated (-) or treated (+) with Tg (300 nM) for 16 hours. PCR was performed with specific primers for the human homologue of mGrp78va shown in Figure 1A. B,C. Quantitative real-time PCR to compare relative expression levels of Grp78va and total Grp78 transcripts in different human cell lines respectively. D. Summary of Grp78va transcript expression in leukemia patients detected by RT-PCR. RNA samples from the indicated types of leukemia patients were used. beta-actin levels served as control. The patient samples are either from peripheral blood or bone marrow (asterisk). The Grp78 transcript levels after normalization against beta-actin in normal individuals and leukemia patients are shown.
###end p 16
###begin p 17
###xml 40 49 40 49 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g002">Figure 2A</xref>
###xml 75 82 75 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 161 166 161 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78</italic>
###xml 256 266 256 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006868.s002">Figure S1C</xref>
###xml 331 340 331 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g001">Figure 1A</xref>
###xml 448 452 448 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Sakabe1">[27]</xref>
###xml 532 537 532 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78</italic>
###xml 634 642 634 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006868.s010">Table S1</xref>
###xml 69 74 <span type="species:ncbi:9606">human</span>
###xml 155 160 <span type="species:ncbi:9606">human</span>
###xml 239 244 <span type="species:ncbi:10090">mouse</span>
###xml 249 254 <span type="species:ncbi:9606">human</span>
###xml 516 521 <span type="species:ncbi:10090">mouse</span>
###xml 526 531 <span type="species:ncbi:9606">human</span>
Sequencing of the PCR products shown in Figure 2A confirmed that the human Grp78va transcript contains the entire 97 bp intron 1 and eight intact exons of human Grp78. The splice donor and acceptor sites for intron 1 are conserved between mouse and human (Figure S1C), however, they do not match the optimal splice site sequences (Figure 1A). The general rules for intron retention are short intron size (around 100 bp) and suboptimal splice sites [27]. Interestingly, in addition to intron 1, intron 4 and 5 of the mouse and human Grp78 also fit these criteria, however, RT-PCR analysis only identified retention for intron 1 and 4 (Table S1).
###end p 17
###begin title 18
###xml 9 16 9 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 76 84 <span type="species:ncbi:9606">patients</span>
Elevated Grp78va expression in ER-stressed leukemic cell lines and leukemia patients
###end title 18
###begin p 19
###xml 176 180 176 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Johnson1">[28]</xref>
###xml 266 271 266 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78</italic>
###xml 439 444 439 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78</italic>
###xml 634 639 634 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78</italic>
###xml 738 747 738 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006868.s004">Figure S3</xref>
###xml 838 845 838 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 982 991 982 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g002">Figure 2B</xref>
###xml 1005 1014 1005 1014 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g001">Figure 1D</xref>
###xml 122 127 <span type="species:ncbi:9606">human</span>
###xml 260 265 <span type="species:ncbi:9606">human</span>
###xml 313 318 <span type="species:ncbi:9606">human</span>
###xml 340 345 <span type="species:ncbi:9606">human</span>
###xml 1028 1033 <span type="species:ncbi:9606">human</span>
###xml 1049 1054 <span type="species:ncbi:10090">mouse</span>
Large-scale microarray using exon-exon junction probes has been used to monitor alternative splicing events in multi-exon human genes by comparing the junction probe intensity [28]. The microarray database deposited in NCBI/GEO contains the expression data of human Grp78 from each exon-exon junction probe in 44 human tissue samples and 8 human cancer cell lines. Comparison of the intensities of exon 1/2 and exon 2/3 junction probes of Grp78 in 52 samples included in this GEO profile revealed that the HL-60 and chronic myeloid leukemia (CML) K562 cell lines have the highest probability to express the intron 1 retention form of Grp78, while adult organs such as the heart, skeletal muscle and cerebral cortex are the most unlikely (Figure S3). The microarray analysis prediction that HL-60 and K562 cells express high levels of the Grp78va transcript whereas cerebral cortex and heart express low levels is in agreement with our measurements using real-time quantitative PCR (Figure 2B) and RT-PCR (Figure 1D) of selected human cell lines and mouse organs.
###end p 19
###begin p 20
###xml 40 47 40 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 222 229 222 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 259 268 259 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g002">Figure 2D</xref>
###xml 274 281 274 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 62 69 <span type="species:ncbi:9606">patient</span>
###xml 130 138 <span type="species:ncbi:9606">patients</span>
###xml 345 353 <span type="species:ncbi:9606">patients</span>
###xml 415 423 <span type="species:ncbi:9606">patients</span>
To further investigate the link between Grp78va and leukemia, patient bone marrow or peripheral blood samples were collected from patients diagnosed with AML, CML, ALL and CLL. The RT-PCR results determining the levels of Grp78va transcript are summarized in Figure 2D. The Grp78va transcript was expressed at various levels in AML, CML and ALL patients, but was below detection limit in normal controls and in CLL patients.
###end p 20
###begin title 21
The GRP78va isoform is a cytosolic protein
###end title 21
###begin p 22
###xml 91 100 91 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g001">Figure 1A</xref>
###xml 328 337 328 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g001">Figure 1A</xref>
###xml 465 474 465 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g003">Figure 3A</xref>
###xml 759 766 759 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 852 861 852 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g003">Figure 3B</xref>
###xml 918 926 918 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1065 1074 1053 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g003">Figure 3C</xref>
###xml 1334 1343 1322 1331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g003">Figure 3B</xref>
###xml 1413 1421 1401 1409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1441 1450 1429 1438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g003">Figure 3C</xref>
###xml 1507 1516 1495 1504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g003">Figure 3D</xref>
###xml 753 758 <span type="species:ncbi:9606">human</span>
###xml 835 838 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
The translation of canonical GRP78 starts from the AUG initiation codon located in exon 1 (Figure 1A). However, retention of intron 1 introduces a UAA stop codon 123 bp downstream of the initial AUG. The next potential translation initiation site is an AUG containing sequence motif in exon 3, which matches the Kozak sequence (Figure 1A). Translation from this AUG site maintains the open reading frame of GRP78, generating a putative GRP78va protein of 507 a.a. (Figure 3A). Compared to GRP78, GRP78va is predicted to have a truncated amino-terminus and lack the ER-targeting signal, however, the remainder of GRP78va isoform will be identical to canonical GRP78 and recognizable by antibodies against the carboxy-terminus of GRP78. To test this, the human Grp78va cDNA was subcloned into the pcDNA3 expression plasmid driven by the CMV/T7 promoter (Figure 3B). This plasmid (pcDNA/Grp78va) was applied to a coupled in vitro transcription and translation assay to express GRP78va. A major protein band with a molecular weight of approximately62 kDa was detected (Figure 3C), which is consistent with the predicted molecular size of GRP78va. Additionally, to achieve higher expression level of GRP78va, pcDNA/Grp78va-sm was constructed where the 5' splice donor site of intron 1 was mutated to inhibit residual splicing of intron 1 (Figure 3B). This mutated plasmid was able to express the 62 kDa GRP78va in the in vitro translation assay (Figure 3C), as well as in the transiently transfected 293T cells (Figure 3D, last lane).
###end p 22
###begin title 23
###xml 20 25 <span type="species:ncbi:9606">human</span>
Characterization of human GRP78va protein.
###end title 23
###begin p 24
###xml 352 360 352 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 524 529 <span type="species:ncbi:9606">human</span>
A. Schematic diagram comparing the protein domains of canonical GRP78 and GRP78va. The carboxy-terminal region recognized by the anti-GRP78 monoclonal antibody (Ab) is indicated. B. Schematic diagram of the indicated GRP78va expression plasmids. The base mutations in the 5' splice site of intron 1 in pcDNA/Grp78va-sm are indicated in red. C. Coupled in vitro transcription and translation assay to detect the protein products from pcDNA/Grp78va and pcDNA/Grp78va-sm plasmids. D. Detection of endogenous GRP78va protein in human cell lines. The post-nuclear (PN) fractions from non-treated or Tg-treated HeLa, HCT116 and HL-60 cells were subjected to Western blot with the anti-GRP78 monoclonal antibody and beta-actin served as loading control. GRP78va expression in 293T cells transfected with pcDNA/Grp78va-sm was used as positive control. A darker exposure of the GRP78va bands is shown below the entire blot. E. Immunofluorescence staining of GRP78 and GRP78va. HeLa cells were transfected with pcDNA-Grp78 (left panel) or pcDNA/HA-Grp78va (right panel). The cells were stained with anti-GRP78 antibody (H-129) or anti-HA antibody as indicated, followed by FITC-conjugated secondary antibodies. The confocal immunofluorescence images are shown. F. Cytosolic localization of GRP78va determined by the cell permeabilization assay. HeLa cells transiently transfected with pcDNA/HA-GRP78va were treated with 0.01% digitonin for 5 minutes. Intact cells, digitonin-permeabilized cells, and the released fraction were analyzed by Western blots for the proteins as indicated.
###end p 24
###begin p 25
###xml 187 196 187 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g003">Figure 3B</xref>
###xml 372 381 372 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g003">Figure 3E</xref>
###xml 851 860 845 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g003">Figure 3F</xref>
To elucidate the subcellular localization of GRP78va, the expression plasmid pcDNA/HA-Grp78va was constructed to allow specific detection of the isoform protein with the HA-tag antibody (Figure 3B). Confocal immunofluorescence microscopy showed diffused cytosolic staining for HA-GRP78va, in contrast to the punctate perinuclear staining for GRP78 typical of ER staining (Figure 3E). Furthermore, digitonin release experiments were performed to differentiate the subcellular localization of canonical GRP78 and GRP78va, with calnexin, a transmembrane ER protein, serving as control for ER protein and beta-actin serving as control for cytosolic protein. Our results showed that GRP78va and beta-actin were released from the cell after disruption of the plasma membrane with low concentration (0.01%) of digitonin, but not canonical GRP78 or calnexin (Figure 3F), confirming that GRP78va is a cytosolic protein.
###end p 25
###begin p 26
###xml 386 395 386 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g003">Figure 3D</xref>
###xml 503 510 503 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 539 548 539 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g002">Figure 2B</xref>
###xml 617 626 617 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g003">Figure 3D</xref>
###xml 767 776 767 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006868.s005">Figure S4</xref>
###xml 942 949 942 949 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 994 1001 994 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 1014 1024 1014 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006868.s006">Figure S5A</xref>
###xml 1227 1239 1227 1239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006868.s006">Figure S5B-D</xref>
###xml 1363 1370 1363 1370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 54 59 <span type="species:ncbi:9606">human</span>
###xml 936 941 <span type="species:ncbi:9606">human</span>
To monitor endogenous GRP78va expression in different human cell lines, post-nuclear (PN) cell lysates were prepared from HeLa, HCT116 and HL-60 cells to enrich for the cytosolic isoform GRP78va. Western blot analyses were performed with the PN fractions from Tg-treated or non-treated cells, with ectopically expressed GRP78va in 293T cells indicating the size of the isoform protein (Figure 3D). In all three cell lines, basal GRP78va expression was detectable, and corresponding with the increase of Grp78va transcript after Tg stress (Figure 2B), GRP78va protein level was also increased in the Tg-treated cells (Figure 3D). Consistent with GRP78va being truncated at the amino-terminus, antibody against the amino-terminus of GRP78 was unable to detect GRP78va (Figure S4). Further, to rule out the possibility that GRP78va is a degraded form of GRP78, a siRNA targeting a 21-nucleotide sequence unique to the retained intron 1 of human Grp78va was utilized to specifically knock down the Grp78va transcript (Figure S5A). In cells transfected with siGrp78va, the level of canonical GRP78 was unchanged at both mRNA and protein levels whereas the level of GRP78va was substantially reduced at both mRNA and protein levels (Figure S5B-D). This, coupled with the different cellular localization for GRP78va and GRP78, indicates that GRP78va is a product of the Grp78va transcript and not a degraded form of GRP78.
###end p 26
###begin title 27
GRP78va specifically enhances PERK signaling in the unfolded protein response
###end title 27
###begin p 28
###xml 426 435 426 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g004">Figure 4A</xref>
###xml 522 531 522 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g004">Figure 4B</xref>
###xml 935 944 927 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g004">Figure 4B</xref>
###xml 1187 1196 1179 1188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g004">Figure 4C</xref>
###xml 1309 1313 1301 1305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xbp1</italic>
###xml 1391 1395 1383 1387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xbp1</italic>
###xml 1499 1503 1491 1495 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xbp1</italic>
###xml 1593 1602 1585 1594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g004">Figure 4D</xref>
Canonical GRP78 is known to interact and regulate the activation of the three major UPR pathways: PERK, IRE1 and ATF6. As a first step to determine the biological function of GRP78va, HeLa cell lines stably transfected with pcDNA/HA-Grp78va or the empty vector were established. Western blot results showed that stable overexpression of GRP78va did not significantly affect the basal level or Tg-induction of canonical GRP78 (Figure 4A). The same cell lysates were analyzed for the status of the UPR pathways. As shown in Figure 4B, overexpression of GRP78va strongly activated the ER eIF2alpha kinase, PERK, as evidenced by increased phosphorylation of PERK, even in the absence of ER stress (time 0). Following Tg treatment, PERK activation was sustained longer than in control cells transfected with the empty vector. This correlates with enhanced and sustained eIF2alpha phosphorylation and higher level of ATF4 upon Tg treatment (Figure 4B). In contrast, we did not observe any significant change in ATF6 activation, as measured by proteolytic cleavage, which may explain why Tg induction of CHOP, co-regulated by ATF6 and ATF4, was not enhanced in the GRP78va overexpressed cells (Figure 4C). ER stress activates the kinase and ribonuclease activities of IRE1, which removes a 26-nucleotide intron from Xbp1 mRNA (Xbp1-u), giving rise to a spliced mRNA (Xbp1-s). While the kinetics of Xbp1 splicing was similar in GRP78va overexpressed and control cells, the ratio of spliced versus unspliced Xbp1 was slightly lower at 2 to 6 hours in GRP78va overexpressed cells than in control cells (Figure 4D).
###end p 28
###begin title 29
GRP78va enhances PERK signaling.
###end title 29
###begin p 30
###xml 942 946 928 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xbp1</italic>
###xml 1024 1028 1010 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xbp1</italic>
A. Western blots to confirm the ectopical expression of GRP78va. HeLa cells stably transfected with vector or pcDNA/HA-Grp78va were treated with Tg (300 nM) for the indicated time. HA-GRP78va and endogenous GRP78 were detected by anti-HA and anti-GRP78 antibody respectively. beta-actin levels served as loading control. B. Western blots were performed to detect the kinetics and magnitude of UPR signaling markers identified on the right following Tg treatment for the indicated time points. The experiments were repeated twice. The representative results are shown with the ratio (p/t) of p-PERK/PERK or p-eIF2alpha/eIF2alpha indicated under each panel with the non-treated control cells set as 1.0. C. Detection of the CHOP activation and ATF6 cleavage following Tg treatment for the indicated time points. The uncleaved (p90) and cleaved (p50) forms of ATF6 are indicated. beta-actin levels served as loading control. D. RT-PCR to detect Xbp1 splicing following Tg treatment for the indicated time. The positions of the Xbp1 unspliced (u) and spliced (s) forms were indicated and the ratio of spliced to unspliced form (s/u) is indicated below. The experiments were repeated three times and the representative results are shown.
###end p 30
###begin p 31
###xml 146 150 146 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Wei1">[29]</xref>
###xml 351 362 351 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g005">Figure 5A,B</xref>
###xml 574 583 570 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g005">Figure 5C</xref>
The ATP binding domain of GRP78 is critical for its catalytic activity, and a single amino acid substitution G227D produced an ATP binding mutant [29]. Stable HeLa cell lines were established with this corresponding mutation in GRP78va (G80D) and the expression level of the mutant form was assayed in parallel with canonical GRP78va by Western blot (Figure 5A,B). Despite a slightly higher expression level of the mutant, it did not lead to enhanced eIF2alpha phosphorylation in non-stressed (time 0) or Tg-treated cells as was observed in the GRP78va overexpressed cells (Figure 5C). These results establish that the ATP binding activity of GRP78va is essential for its positive regulatory function and further excludes the possibility that GRP78va overexpression fortuitously triggered PERK signaling as a consequence of ectopic protein expression.
###end p 31
###begin title 32
Mutation in ATP binding domain of GRP78va attenuates eIF2alpha phosphorylation.
###end title 32
###begin p 33
###xml 887 894 868 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 909 914 890 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78</italic>
###xml 1173 1180 1154 1161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 1194 1199 1175 1180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78</italic>
###xml 1316 1319 1297 1300 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 1624 1627 1594 1597 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 31 36 <span type="species:ncbi:9606">human</span>
A. Schematic representation of human GRP78, GRP78va, and the ATP binding mutant GRP78va-G80D. The position of mutation site is indicated. B. Western blots to detect ectopic expression of GRP78va and the mutant in stably transfected HeLa cell lines. The GRP78va proteins and endogenous canonical GRP78 were detected by the anti-HA and anti-GRP78 antibody respectively, with beta-actin as loading control. C. Time course analysis of eIF2alpha phosphorylation in Tg-treated HeLa cells stably expressing HA-GRP78va or the mutant. Western blots were performed to determine total and phospho-eIF2alpha levels (upper panel). The ratio of phospho-eIF2alpha to total eIF2alpha from two independent experiments are summarized and expressed as the mean with the indicated standard deviation (SD) (lower panel). P values for all time points are indicated. D. Time course analyses of Tg induction of Grp78va and canonical Grp78 transcripts by RT-PCR. HL-60 cells were treated with Tg (300 nM) for the indicated time and the total RNA was subjected to RT-PCR (left panel). The experiments were repeated three times. The results are summarized and expressed as the mean of the normalized Grp78va or canonical Grp78 levels with the indicated SD (right panel). E. Time course analyses of Tg induction of canonical GRP78, GRP78va, P58IPK and eIF2alpha phosphorylation (p-eIF2alpha). HL-60 cells treated with Tg (300 nM) for the indicated time were used for Western blot for detection of the indicated proteins with beta-actin as loading control (left panel). The experiments were repeated twice. The levels of canonical GRP78, GRP78va and P58IPK normalized to beta-actin and the ratio of phospho-eIF2alpha to total eIF2alpha are summarized and plotted respectively (right panel).
###end p 33
###begin p 34
###xml 509 518 489 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g005">Figure 5D</xref>
###xml 540 549 520 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g005">Figure 5E</xref>
###xml 614 617 594 597 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 713 722 693 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g005">Figure 5E</xref>
###xml 782 785 762 765 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 871 875 851 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Yan1">[30]</xref>
###xml 997 1006 973 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g005">Figure 5E</xref>
To investigate further the relationship between endogenous GRP78va and PERK activation, we first monitored in HL-60 cells the kinetics of Tg-induced expression of GRP78va and phosho-eIF2alpha as a monitor for PERK activation. GRP78 and total eIF2alpha levels were also measured in parallel. Representative gels/blots and a summary of quantified results from multiple experiments are shown. The upregulation of GRP78va started at an early stage (approximately2 hours) following Tg treatment, at both the mRNA (Figure 5D) and protein levels (Figure 5E) and the increase was sustained for 16 hours. Interestingly, P58IPK, a known inhibitor of PERK, was also quickly induced (from 2 hours) during the same treatment (Figure 5E), which is different from the previous observation that P58IPK is induced at late phase (12 hours) of tunicamycin-induced ER stress in NIH3T3 cells [30]. Elevation of eIF2alpha phosphorylation was evident within the first hour and sustained throughout the treatment period (Figure 5E).
###end p 34
###begin title 35
###xml 26 29 26 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
GRP78va interacts with P58IPK and reduces its protein level
###end title 35
###begin p 36
###xml 3 6 3 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 102 105 102 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 136 140 136 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-vanHuizen1">[21]</xref>
###xml 226 229 226 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 397 400 397 400 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 453 456 453 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 555 564 555 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g006">Figure 6A</xref>
###xml 609 612 609 612 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 721 724 721 724 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 782 785 782 785 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 787 796 787 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g006">Figure 6B</xref>
###xml 839 842 839 842 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 960 963 960 963 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 1011 1020 1011 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g006">Figure 6B</xref>
P58IPK is an inhibitor of PERK acting through the cytosolic kinase domain of PERK and knockdown of P58IPK constitutively activates PERK [21]. Since GRP78va activates PERK signaling, we tested whether GRP78va diminishes the P58IPK inhibitory effect on PERK through protein-protein interaction. Co-immunoprecipitation was performed with lysates from 293T cells co-transfected with HA-GRP78va and P58IPK-FLAG, where the FLAG-tag was fused to the ORF of P58IPK at the carboxy-terminus, so that it does not interfere with the amino-terminal ER signal peptide (Figure 6A). GRP78va was co-immunoprecipitated with P58IPK in both non-stressed and Tg-treated cells. Co-immunoprecipitation of GRP78va was also observed with FLAG-P58IPK where the FLAG-tag was fused to the amino-terminus of P58IPK (Figure 6B). Furthermore, the interaction between P58IPK and GRP78va requires the ATP binding function of GRP78va as the binding of the ATP binding mutant GRP78va-G80D to P58IPK was much weaker compared to wild-type GRP78va (Figure 6B).
###end p 36
###begin title 37
###xml 60 63 60 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
Physical and functional interactions between GRP78va and P58IPK.
###end title 37
###begin p 38
###xml 45 48 45 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 90 93 90 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 431 434 431 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 520 523 520 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 707 710 707 710 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 807 810 807 810 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 957 960 957 960 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 984 987 984 987 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 1147 1150 1147 1150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 1252 1255 1248 1251 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 1609 1612 1597 1600 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 1826 1829 1814 1817 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 1931 1934 1916 1919 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 2030 2037 2015 2022 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 2080 2083 2065 2068 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 2197 2200 2179 2182 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 300 305 <span type="species:ncbi:10090">mouse</span>
A. Co-immunoprecipitation of GRP78va with P58IPK. 293T cells co-transfected with pcDNA/P58IPK-FLAG (schematic drawing shown above) and pcDNA/HA-Grp78va were either non-treated (-) or treated with Tg (300 nM) for 16 hours. Immunoprecipitations were performed with either anti-FLAG antibody or control mouse IgG, followed by Western blot with the respective antibodies. The input levels are shown. B. Reduced binding between FLAG-P58IPK and ATP binding mutant of GRP78va. 293T cells were co-transfected with pcDNA/FLAG-P58IPK and pcDNA/HA-Grp78va or the mutant Grp78va-G80D. Immunoprecipitations were performed with anti-FLAG antibody or control IgG, followed by Western blot. C. Cytosolic localization of P58IPK determined by the cell permeabilization assay. HeLa cells transiently transfected with pcDNA/P58IPK-FLAG were permeabilized by 0.01% digitonin for 5 minutes. The various fractions were subjected to Western blots for the proteins as indicated. P58IPK-FLAG(SS) designates P58IPK with a slower electrophoretic mobility being released from the permeabilized cells, consistent with retention of signal sequence. D. Overexpression of FLAG-P58IPK suppressed eIF2alpha phosphorylation mediated by GRP78va. Following transient transfection of the P58IPK expression plasmid or vector into the indicated stably transfected HeLa cell lines, Western blots were performed to probe for the indicated proteins. The experiments were repeated twice. The representative Western blots are shown with the ratio (p/t) of phospho-eIF2alpha to total eIF2alpha indicated. E. Overexpression of GRP78va reduced endogenous P58IPK levels. Western blots were performed in HeLa cells stably transfected with vector or HA-GRP78va expression plasmid. The experiments were repeated three times. The representative Western blots are shown and the P58IPK levels normalized to beta-actin are indicated below. F. Knockdown of GRP78va increased endogenous P58IPK level. Western blots were performed with HeLa cells transfected with control siRNA (siCtrl) or Grp78va siRNA (siGrp78va) to detect endogenous P58IPK and beta-actin level. The cells were either non-treated (-) or treated (+) with Tg (300 nM) for 16 hours. The P58IPK levels normalized to beta-actin are shown below the immunoblots. Statistical comparisons were made between Tg-treated cells transfected with siCtrl or siGrp78va, p = 0.03.
###end p 38
###begin p 39
###xml 62 65 62 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 168 172 168 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Lee4">[20]</xref>
###xml 174 178 174 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Yan1">[30]</xref>
###xml 218 221 218 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 287 291 287 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Rutkowski3">[23]</xref>
###xml 293 297 293 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Petrova1">[31]</xref>
###xml 417 421 417 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Rutkowski3">[23]</xref>
###xml 513 516 513 516 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 592 601 592 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006868.s007">Figure S6</xref>
###xml 644 647 644 647 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 860 863 860 863 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 890 893 890 893 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 1034 1043 1034 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g006">Figure 6C</xref>
###xml 1116 1119 1116 1119 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 1236 1239 1236 1239 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 1311 1315 1311 1315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Rutkowski3">[23]</xref>
###xml 1317 1321 1317 1321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Petrova1">[31]</xref>
###xml 1338 1341 1338 1341 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 1407 1411 1407 1411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Rutkowski3">[23]</xref>
###xml 1489 1492 1489 1492 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
Since GRP78va is a cytosolic protein, its interaction with P58IPK is expected to occur in the cytosolic compartment. While originally discovered as a cytosolic protein [20], [30], recent evidence suggests that most P58IPK is located in the ER lumen as a co-chaperone of ER lumenal GRP78 [23], [31], however its weak signal sequence allows for inefficient translocation and may therefore generate some cytosolic forms [23]. Through confocal microscopy using PDI staining as an ER marker, we observed that while P58IPK-FLAG co-localized with PDI in the ER, it was also detected in the cytosol (Figure S6). The existence of a cytosolic pool of P58IPK was further confirmed by digitonin release experiment, with the heat shock protein HSP70 serving as control for cytosolic protein and calnexin serving as control for ER protein. In HeLa cells transfected with P58IPK-FLAG, we observed that P58IPK and HSP70, but not calnexin, was detected in the released fraction when the cells were treated with low concentration (0.01%) of digitonin (Figure 6C). Additionally, the electrophoretic mobility of the released form of P58IPK was slower than the form that was retained inside the permeabilized cells, consistent with previous reports that P58IPK bearing the signal peptide migrated slower than the ER form in SDS gel [23], [31] and the weak P58IPK signal sequence allows for inefficient translocation into the ER [23]. Thus, both imaging and biochemical studies suggest that a subfraction of P58IPK can exist in the cytosolic compartment.
###end p 39
###begin p 40
###xml 80 83 80 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 253 256 249 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 323 326 319 322 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 375 384 367 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g006">Figure 6D</xref>
###xml 408 411 400 403 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 484 487 476 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 565 568 557 560 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 577 586 569 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g006">Figure 6E</xref>
###xml 626 629 618 621 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 718 721 710 713 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 771 780 763 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g006">Figure 6F</xref>
Next we examined whether there is functional interaction between GRP78va and P58IPK. In HeLa cells stably expressing GRP78va, the level of phospho-eIF2alpha level was increased by 5.6-fold compared to vector control; however, upon co-expression with P58IPK, this level was reduced to 1.9-fold; whereas overexpression of P58IPK alone had no effect on phospho-eIF2alpha level (Figure 6D). This implies that P58IPK is an antagonist of GRP78va. Conversely, GRP78va is an antagonist of P58IPK since stable overexpression of GRP78va in HeLa cells decreased endogenous P58IPK by 70% (Figure 6E). Further, modulation of endogenous P58IPK by endogenous GRP78va in Tg treated cells was demonstrated by a 2.8-fold increase in P58IPK level where GRP78va was down-regulated by siRNA (Figure 6F).
###end p 40
###begin title 41
GRP78va protects leukemic cells against ER stress-induced cell death
###end title 41
###begin p 42
###xml 155 159 151 155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Bi1">[32]</xref>
###xml 161 165 157 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Blais1">[33]</xref>
###xml 491 500 487 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g007">Figure 7A</xref>
###xml 521 530 517 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g007">Figure 7B</xref>
###xml 692 701 684 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g007">Figure 7C</xref>
###xml 880 889 872 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g007">Figure 7D</xref>
###xml 1020 1029 1012 1021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g007">Figure 7E</xref>
###xml 1135 1145 1127 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006868.s008">Figure S7A</xref>
###xml 1206 1216 1198 1208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006868.s008">Figure S7B</xref>
Translational attenuation mediated by eIF2alpha phosphorylation is a major pro-survival mechanism for the UPR and promotes tumor cell adaptation to stress [32], [33]. Given that leukemia is a highly malignant disease, GRP78va expression in leukemic cells may regulate PERK signaling and offer protection against ER stress-induced apoptosis, leading to survival. To test this, HL-60 cells were transfected with siGrp78va or control siRNA, and specific knockdown of GRP78va at the transcript (Figure 7A) and protein level (Figure 7B) was confirmed. Compared to control siRNA, cells transfected with siGrp78va showed significant attenuation of eIF2alpha phosphorylation induced by Tg treatment (Figure 7C). Western blot analyses further showed increased levels of the cleaved products of caspase-3 and -7 in Tg-treated cells transfected with siGrp78va, as compared to control siRNA (Figure 7D), corresponding with decrease in cell survival as measured by soft agar clonogenic assay in cells where GRP78va was knocked down (Figure 7E). Similarly, in colony survival assays, knockdown of GRP78va reduced viability of Tg-treated HeLa cells (Figure S7A), whereas overexpression of GRP78va enhanced cell survival (Figure S7B).
###end p 42
###begin title 43
GRP78va protects HL-60 cells from ER stress-induced cell death.
###end title 43
###begin p 44
###xml 148 155 148 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
A, B. Knockdown of GRP78va in HL-60 cells. RT-PCR (A, left panel) or quantitative real-time PCR (A, right panel) was used to determine the level of Grp78va transcript in HL-60 cells transfected with the indicated siRNA. Western blot. B was performed to determine the levels of the proteins indicated. C. Inhibition of Tg-induced eIF2alpha phosphorylation by knockdown of GRP78va. HL-60 cells were transfected with either siCtrl or siGrp78va. After treatment with Tg (300 nM) for the indicated time, phospho-eIF2alpha and total eIF2alpha were detected by Western blot (upper panel). The experiments were repeated three times. The results are summarized and the ratio of p-eIF2alpha/eIF2alpha is plotted with SD (lower panel). The ratio of the non-treated, siCtrl transfected cells was set as 1. P values are indicated. D. Western blot of caspase-7, cleaved caspase-3 and beta-actin in siRNA-transfected HL-60 cells treated with Tg for 24 hours. E. Soft-agar clonogenic survival assay for HL-60 cells after transfection with the indicated siRNA for 72 hours and then treated with Tg (300 nM) for the indicated time.
###end p 44
###begin title 45
Discussion
###end title 45
###begin p 46
###xml 318 322 318 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Schwerk1">[24]</xref>
###xml 456 459 456 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Hendershot1">[4]</xref>
###xml 461 465 461 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Ni1">[16]</xref>
###xml 527 531 527 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Liu1">[34]</xref>
###xml 533 537 533 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Arap1">[35]</xref>
###xml 722 726 722 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Lee3">[15]</xref>
###xml 728 732 728 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Wang1">[17]</xref>
###xml 734 738 734 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Misra1">[36]</xref>
###xml 739 743 739 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Shani1">[40]</xref>
###xml 859 864 859 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78</italic>
###xml 1049 1052 1049 1052 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
Alternative splicing is a major mechanism for generating protein diversity, expressing proteins that are related but with diverse function and localization. Interestingly, a large number of apoptotic regulators undergo alternative splicing, suggesting that this is a crucial mechanism for survival and death decisions [24]. GRP78/BiP, which represents a major anti-apoptotic arm of the UPR, has been traditionally regarded as an ER lumen chaperone protein [4], [16]. Recently, GRP78 has also been localized on the cell surface [34], [35]. Although the amount of surface GRP78 represents only a very small fraction of cellular GRP78, it has been implicated in enhancing mitogenic signaling, proliferation and cell survival [15], [17], [36]-[40]. Here, we report the discovery of GRP78va, a novel cytosolic isoform of GRP78 generated by alternative splicing of Grp78 nuclear pre-mRNA. Our findings suggest the ability of GRP78va to mediate a previously unanticipated positive feedback regulation of PERK, potentially via cytosolic interaction with P58IPK. Our studies reveal several novel observations which may have important clinical implications in leukemia and other pathophysiological conditions that express this isoform.
###end p 46
###begin p 47
###xml 334 341 334 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 655 659 651 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Gardner1">[41]</xref>
###xml 882 889 878 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 987 994 983 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 1315 1322 1311 1318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 1379 1386 1375 1382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 1460 1465 1456 1461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78</italic>
###xml 1580 1587 1576 1583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 1637 1646 1633 1642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006868.s006">Figure S5</xref>
###xml 1702 1709 1698 1705 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 1866 1876 1862 1872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006868.s009">Figure S8A</xref>
###xml 2014 2024 2010 2020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006868.s009">Figure S8B</xref>
###xml 2145 2155 2141 2151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006868.s009">Figure S8C</xref>
###xml 2419 2423 2415 2419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Rechsteiner1">[42]</xref>
###xml 2425 2429 2421 2425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Rogers1">[43]</xref>
###xml 2691 2698 2687 2694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 2957 2961 2953 2957 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Johnson1">[28]</xref>
###xml 2735 2740 <span type="species:ncbi:10090">mouse</span>
###xml 2840 2848 <span type="species:ncbi:9606">patients</span>
Why has GRP78va escaped detection despite extensive studies on the structure and function of GRP78/BiP over the past 25 years? Difficulty to detect the isoform proteins generated from alternative spliced mRNAs could be due to transcript instability, reduced translation efficiency or instability of the new proteins. The abundance of Grp78va mRNA may be affected by nonsense-mediated RNA decay (NMD). NMD is a quality-control mechanism that selectively degrades mRNAs harboring premature termination (nonsense) codons. Most recently, it was reported that NMD is inhibited in ER-stressed cells and this inhibition is dependent on eIF2alpha phosphorylation [41]. The repression of NMD stabilizes the target mRNAs, including the UPR factors ATF4, ATF3 and CHOP, and thereby arguments the cellular stress response. With the introduction of a premature stop codon by intron 1 retention, Grp78va mRNA is a potential NMD target. Upon ER stress, inhibition of NMD could lead to stabilization of Grp78va mRNA and translation of functional GRP78va protein. Since GRP78va initiates by an internal AUG that is also contained in the canonical GRP78 transcript, the issue arises whether internal initiation might also occur. In our experimental design, the siRNA against GRP78va specifically targets the retained intron 1 of the Grp78va transcript, thereby affecting only translation from the Grp78va transcript but not internal initiation from the fully spliced, canonical Grp78 transcript. We observed that the decrease in GRP78va protein level generally corresponds with the decrease in the Grp78va transcript level in the siGrp78va-treated cells (Figure S5), suggesting that the majority of GRP78va results from Grp78va mRNA translation. At the post-translational level, HA-GRP78va, was stabilized by the proteasome inhibitor MG115, whereas endogenous GRP78 was not affected (Figure S8A), consistent with a much shorter half life for GRP78va compared to canonical GRP78, as determined by the cycloheximide chase experiment (Figure S8B). Analysis of the protein amino acid sequence revealed a potential PEST-rich region at the carboxy-terminus of GRP78va (Figure S8C). PEST sequences are present in regulatory proteins, such as transcription factors, protein kinases or phosphatases and cyclins, and often locate at carboxy-terminus in these proteins, serving as a proteolytic signal contributing to rapid degradation of proteins [42], [43]. While canonical GRP78 also contains the same PEST sequence, the ER compartment where it is localized likely protects it from recognition and degradation by ubiquitin-proteasome system. Here we report that with the proper PCR primers, the alternatively spliced Grp78va transcript is readily detectable in mouse embryos, specific adult tissues, as well as peripheral blood and bone marrow samples from leukemic patients. The GRP78va expression pattern matches well with predictions from the genome-wide exon junction microarray [28] and is represented, albeit rarely, in the current expressed sequence tag (EST) database which tends to bias against less abundant alternative forms. While GRP78va may have diverse cellular function which awaits future investigation, here we establish that GRP78va exhibits anti-apoptotic activity against ER stress.
###end p 47
###begin p 48
###xml 353 357 353 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Gaut1">[44]</xref>
How might GRP78va protect cells from ER stress induced cell death? In contrast to canonical GRP78, GRP78va is cytosolic due to the lack of the amino-terminal ER signal sequence. Based on previous studies of GRP78 mutants, the GRP78va isoform corresponds to the protein initiating at Met-148/153 which showed greater ATP binding than the wild-type GRP78 [44]. Thus, the conservation of both the ATP binding and the peptide binding domains in GRP78va suggests that it can act as a cytosolic counterpart of canonical GRP78, interacting with client proteins playing critical roles in cell survival. One key function of the ER localized canonical GRP78 is its ability to regulate ER stress signaling by maintaining ER transmembrane sensors PERK, IRE1 and ATF6 in their inactive state in non-stressed cells. As a first test of GRP78va function, we examined whether it affects ER stress signaling pathways. Using both overexpression and knockdown approaches, we discovered that GRP78va selectively upregulates PERK signaling. Further, point mutation of GRP78va defective in ATP binding greatly diminished its regulatory effect on induction of eIF2alpha phosphorylation, suggesting that GRP78va acts through its interaction with cytosolic client protein(s) capable of modulating PERK activity.
###end p 48
###begin p 49
###xml 22 25 22 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 154 157 154 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 245 248 245 248 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 364 368 364 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Lee4">[20]</xref>
###xml 370 374 370 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Rutkowski3">[23]</xref>
###xml 376 380 376 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Yan1">[30]</xref>
###xml 562 566 562 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Levine1">[45]</xref>
###xml 657 661 657 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Afshar1">[46]</xref>
###xml 791 795 791 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Garcia1">[47]</xref>
###xml 897 901 897 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Duriez1">[48]</xref>
###xml 985 989 985 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Afshar1">[46]</xref>
###xml 991 998 991 998 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Results</xref>
###xml 1083 1086 1083 1086 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 1115 1119 1115 1119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Rutkowski3">[23]</xref>
###xml 1185 1188 1185 1188 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 1256 1260 1256 1260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Lee4">[20]</xref>
###xml 1262 1266 1262 1266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Yan1">[30]</xref>
###xml 1311 1315 1311 1315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Oyadomari1">[22]</xref>
###xml 1348 1351 1348 1351 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 1459 1463 1459 1463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Goodman1">[49]</xref>
###xml 1514 1517 1514 1517 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 1671 1674 1671 1674 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 1712 1715 1712 1715 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 2043 2046 2043 2046 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 1795 1800 <span type="species:ncbi:10090">mouse</span>
###xml 1837 1842 <span type="species:ncbi:9606">human</span>
Here we identified P58IPK as the first client protein of GRP78va. There are some discrepancies in literature regarding the subcellular localization of P58IPK, as its activity has been documented in both the cytosolic and the ER compartments. P58IPK was originally discovered as a cytosolic protein but later discovered to possess a weak ER signal peptide sequence [20], [23], [30]. There are precedents in literature where an ER protein can also localize in the cytosol. Potential mechanisms include inefficient translocation due to weak signal peptide sequence [45], retrotranslocation from the ER lumen to the cytosol after peptide cleavage inside the ER [46]; after signal peptide cleavage but prior to ER insertion, translocation can be aborted and the product released into the cytosol [47]; and retrotranslocation from the ER lumen to the cytosol via ERAD but escapes proteasome degradation [48]. Further, different cell lines exhibit wide variations in the extent of relocation [46]. Results from our studies in HeLa cells are consistent with insufficient translocation of P58IPK due to weak signal sequence [23], and provide a plausible explanation for the original role of P58IPK as an inhibitor of the cytosolic kinase activities of PERK and PKR [20], [30], as a cytosolic component of the translocon [22], and the recent finding that P58IPK regulates influenza virus mRNA translation and replication through a PKR-mediated mechanism in the cytosol [49]. Further, as the minor cytosolic population of P58IPK is able to inhibit the low abundance PERK or PKR kinase, this inhibition could be suppressed by low amount GRP78va through antagonizing the cytosolic P58IPK. In addition, the distribution of P58IPK between the ER and cytosol could be different in different cell types, such as mouse embryonic fibroblasts (MEFs) versus human cancer cells, or under different cellular conditions, such as normal physiological versus pathological conditions. Future investigations will be required to resolve how these factors contribute to P58IPK subcellular localization and function.
###end p 49
###begin p 50
###xml 340 344 340 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Qiu1">[50]</xref>
###xml 346 350 346 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Fan1">[51]</xref>
###xml 605 609 605 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Shen1">[52]</xref>
###xml 610 614 610 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Kurisu1">[54]</xref>
###xml 787 790 787 790 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 1199 1203 1199 1203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Gaut1">[44]</xref>
Our results also predict that other cytosolic co-chaperone proteins might associate with GRP78va and assist its function. It is known that Hsp70 proteins employ DnaJ family proteins as co-chaperones, which preferentially bind to the ATP form of their partner Hsp70 and stimulate the ATPase activity to stabilize Hsp70-polypeptide complexes [50], [51]. DnaJ/Hsp40 chaperone proteins interact with the conserved ATPase domain of HSP70 proteins through their conserved J-domain. As the ER lumenal HSP70 chaperone, GRP78 is known to interact with a group of DnaJ/Hsp40 proteins in the ER lumen, such as ERdjs [52]-[54]. Since GRP78va retains most part of ATPase domain of canonical GRP78, it is expected to potentially bind other cytosolic chaperones, such as DnaJ/Hsp40 proteins besides P58IPK. Further experiments are necessary to characterize the cytosolic co-chaperone proteins of GRP78va. It is also tempting to speculate that GRP78va might act as a cytosolic chaperone collaborating with its cytosolic co-chaperones to promote the folding of nascent cytosolic polypeptides, since it corresponds to the GRP78 mutant initiated from Met-148 in previous study and exhibits strong ATP binding activity [44], implicating that GRP78va has the ability to bind to client proteins.
###end p 50
###begin p 51
###xml 566 569 562 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Li1">[5]</xref>
###xml 571 575 567 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Lee3">[15]</xref>
###xml 577 581 573 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Bi1">[32]</xref>
###xml 583 587 579 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Blais1">[33]</xref>
###xml 589 593 585 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Ranganathan1">[55]</xref>
###xml 595 599 591 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Li2">[56]</xref>
###xml 604 607 600 603 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 683 686 679 682 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 922 925 918 921 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 971 974 967 970 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 1015 1018 1011 1014 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 1073 1076 1069 1072 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 1393 1397 1389 1393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Ladiges1">[57]</xref>
###xml 1488 1492 1484 1488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Lin1">[19]</xref>
Induction of GRP78 and activation of PERK signaling represents two major pro-survival pathways in the UPR. GRP78 promotes ER protein folding and efficient degradation of aggregated proteins through ERAD, which alleviates the unfolded protein load in the ER and increases cell survival. Likewise, PERK-mediated eIF2alpha phosphorylation is protective by attenuating the protein biosynthesis and consequently reducing the total protein load on the ER. Thus, both GRP78 upregulation and PERK activation promote cell survival and adaptation to pathophysiological stress [5], [15], [32], [33], [55], [56]. P58IPK is inducible by ER stress. The cells employ the cytosolic population of P58IPK to inhibit PERK activity, allowing the cells to recover from global translational inhibition. Our data suggests that ER stress also induces GRP78va as a cytosolic counterpart of GRP78, and a potential feedback mechanism to regulate P58IPK. Through complex formation with cytosolic P58IPK, GRP78va may act as an antagonist of P58IPK. Thus, when GRP78va is overexpressed, the level of P58IPK was decreased and PERK signaling was enhanced. Therefore, GRP78va has the ability to function as a novel regulator of PERK signaling under ER stress and this regulation may play an important role especially in cancer cells where GRP78va is highly expressed. However, since sustained PERK activation could be harmful [57] and persistent ER stress attenuates survival pathways mediated by IRE1 and ATF6 signaling [19], this may explain why GRP78va expression might be stringently regulated at the transcript stability level, as well as at the post-translational level.
###end p 51
###begin p 52
###xml 90 94 90 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Pajares1">[25]</xref>
###xml 554 558 554 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Salesse1">[58]</xref>
###xml 560 564 560 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Theoleyre1">[59]</xref>
###xml 614 619 614 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78</italic>
###xml 208 216 <span type="species:ncbi:9606">patients</span>
###xml 632 640 <span type="species:ncbi:9606">patients</span>
Aberrant splicing has been found to be associated with various diseases, including cancer [25]. In this study, through microarray and biochemical analysis, we discovered that leukemic cell lines and leukemia patients expressed high levels of GRP78va. Evidence suggests that alteration of phosphorylation and/or expression of proteins that recognize splice sites and assembly of the splicesome in leukemia can be caused by aberrant BCR/ABL fusion protein, deregulated expression of DNA topoisomerase I or the hematopoietic transcription factor Spi-1/PU.1 [58], [59]. Thus, a higher incidence of intron retention of Grp78 in leukemic patients may be due to alteration of the pre-mRNA splicing machinery. On the other hand, genomic mutations associated with oncogenesis may also interfere with the recognition and selection of splice sites and affect pre-mRNA splicing pattern.
###end p 52
###begin p 53
###xml 321 325 317 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Khan1">[60]</xref>
###xml 327 331 323 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Zhang1">[61]</xref>
###xml 559 563 555 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Pattacini1">[62]</xref>
###xml 737 741 733 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Ota1">[63]</xref>
###xml 947 950 943 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Li1">[5]</xref>
###xml 952 956 948 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Lee3">[15]</xref>
###xml 958 962 954 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Ranganathan1">[55]</xref>
###xml 964 968 960 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Dong1">[64]</xref>
###xml 969 973 965 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Baumeister1">[69]</xref>
###xml 728 736 <span type="species:ncbi:9606">patients</span>
Considering the high expression of GRP78va in leukemia and its pro-survival role against ER stress, how might leukemic cells experience ER stress? Recent reports suggest that retroviral infection, the pathologically expressed fusion protein PML-RARalpha and reactive oxygen species can induce ER stress in leukemic cells [60], [61]. Therapeutic drugs in clinical treatment or pre-clinical test, such as arsenic trioxide and imatinib mesylate, have been shown to upregulate ER stress markers and induce leukemic cell death through ER stress-mediated apoptosis [62]. Further, proteomic analysis discovered that GRP78 is differentially expressed in the hematopoietic stem cell (HSC)-like fractions from the bone marrow of leukemia patients [63]. It will be interesting to determine if GRP78va is also elevated in parallel with GRP78 in the HSC cell fractions. While GRP78 is established to be critical for solid tumor progression and drug resistance [5], [15], [55], [64]-[69], the role of GRP78 and GRP78va in hematological cancers remains to be determined. The discovery of the novel cytosolic isoform GRP78va points to a new paradigm for how GRP78 functions in regulating cell homeostasis and future identification of other client proteins of GRP78va will yield new insight on how GRP78 and UPR signaling regulate cell survival and death beyond the ER compartment.
###end p 53
###begin title 54
Materials and Methods
###end title 54
###begin title 55
Cell culture
###end title 55
###begin p 56
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 73 78 <span type="species:ncbi:10090">mouse</span>
###xml 181 187 <span type="species:ncbi:9913">bovine</span>
###xml 226 231 <span type="species:ncbi:9606">Human</span>
###xml 364 370 <span type="species:ncbi:9913">bovine</span>
Human cell lines HeLa, MDA-MB-435, HCT116, A549, MCF-7, HBL100, 293T and mouse fibroblast NIH3T3 cells were cultured in Dulbecco's modified Eagle medium (DMEM) containing 10% fetal bovine serum and 1% penicillin/streptomycin. Human lymphoma cell line Raji, APL cell line HL-60 and CML cell line K562 were maintained in RPMI 1640 medium supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin.
###end p 56
###begin title 57
RT-PCR and quantitative real-time PCR
###end title 57
###begin p 58
###xml 835 840 833 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78</italic>
###xml 844 851 842 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 869 878 867 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g001">Figure 1A</xref>
###xml 925 950 923 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006868.s001">Supporting Information S1</xref>
###xml 30 35 <span type="species:ncbi:10090">mouse</span>
###xml 325 330 <span type="species:ncbi:9606">human</span>
Total RNA from cell cultures, mouse embryos and tissues was extracted by Trizol reagent (Invitrogen) and treated with DNase I before converted to cDNA by using SuperScript II reverse transcriptase (Invitrogen) with oligo d(T) primer following the manufacturer's instruction. For quantitative real-time PCR, cDNA samples from human cell lines were analyzed in triplicate with the SYBR(R) Green Supermix (BioRad) using iCycler Real-Time PCR Detection System (BioRad). All primer sets were tested for PCR efficiency as recommended by the manufacturer's instruction. A standard curve was prepared for each set of primers using serial titration of the cDNA samples. The relative mRNA level was calculated from primer-specific standard curves using the iCycler Data Analysis Software and normalized to GAPDH levels. Specific PCR primers for Grp78 or Grp78va are indicated in Figure 1A and the sequence of primers are listed in the Supporting Information S1.
###end p 58
###begin title 59
cDNA cloning and plasmid construction
###end title 59
###begin p 60
###xml 55 62 55 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 177 202 177 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006868.s001">Supporting Information S1</xref>
###xml 49 54 <span type="species:ncbi:9606">human</span>
Bridging-based two round PCR was used to amplify human Grp78va cDNA sequence and the cloning procedure for the construction of all the expression plasmids were described in the Supporting Information S1. All the clones were verified by sequencing.
###end p 60
###begin title 61
Clinical specimens
###end title 61
###begin p 62
###xml 209 217 <span type="species:ncbi:9606">patients</span>
###xml 322 327 <span type="species:ncbi:9606">human</span>
Leukemic blasts from bone marrow and peripheral blood samples were generously provided by Dr. Allen Yang (University of Southern California Keck School of Medicine). They were obtained from diagnosed leukemia patients in USC/Norris Comprehensive Cancer Center according to institutional guidelines. The ethical use of the human tissues for research was approved by the University of Southern California Institutional Review Board. Written consent was obtained.
###end p 62
###begin title 63
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
In vitro transcription and translation assay
###end title 63
###begin p 64
One microg of the template plasmid DNA was applied in the TNT(R) quick coupled transcription/translation assay (Promega) following the manufacturer's protocol.
###end p 64
###begin title 65
Transfection methods
###end title 65
###begin p 66
###xml 571 578 554 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Grp78va</italic>
###xml 619 644 602 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006868.s001">Supporting Information S1</xref>
For transfection of plasmids, Polyfect reagent (Qiagen) was used following the manufacturer's protocol. The stable cell lines were established by transfecting the expression plasmids into HeLa cells, followed by selection with G418 (400 microg/ml, Gibco) for 2 weeks. Individual clones were picked, trypsinized and seeded to 24 well-plate for further culture in fresh DMEM medium supplemented with G418 (200 microg/ml). For transfection of siRNA, Lipofectaminetrade mark 2000 reagent (Invitrogen) was used following manufacturer's protocol. The sequence of siRNA against Grp78va and control siRNA were described in the Supporting Information S1.
###end p 66
###begin title 67
Preparation of post-nuclear lysate
###end title 67
###begin p 68
###xml 91 92 91 92 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Cells were resuspended in ice cold NE buffer A (10 mM Hepes, pH 7.9, 10 mM KCl, 1.5 mM MgCl2, 10 mM EDTA, 0.35% NP-40, 1x protease inhibitor complex), rotated at 4degreesC for 10 minutes and centrifuged to collect the supernatant as the PN fraction, which were stored in -80degreesC for further analysis.
###end p 68
###begin title 69
Cell permeabilization
###end title 69
###begin p 70
###xml 132 136 132 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Afshar1">[46]</xref>
###xml 155 156 155 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
Digitonin was used to selectively permeabilize the plasma membrane of cells but not the organelle membrane, as previously described [46]. Briefly, about 106 HeLa cells were transfected with the indicated expression vectors. After 48 hours, the cells were trypsinized and collected by centrifugation. Half of the cells were lysed in 500 microl of RIPA buffer supplemented with competent protease-inhibitor cocktail (Roche), and the other half were resuspended in 500 microl of transport buffer (20 mM HEPES, pH 7.4, 110 mM potassium acetate, 2 mM magnesium acetate, 0.5 mM EGTA) supplemented with proteinase inhibitor cocktail. Cell permeabilization was carried out in 0.01% digitonin for 5 minutes on ice. The supernatant and pellet were collected by centrifugation. The cell pellet was resuspended in 500 microl of RIPA buffer. Equivalent volumes of intact cells, permeabilized cells, and the released fraction were analyzed by Western blot.
###end p 70
###begin title 71
Western blot analysis
###end title 71
###begin p 72
Cells were lysed in RIPA buffer supplemented with competent protease-inhibitor mixture (Roche) and 50 microg cell lysate was subjected to SDS-PAGE. The immunoblot membranes were probed with primary antibody and the protein signals were detected with the ECL reagent (Roche) or Supersignal chemiluminescence reagent (PIERCE) after reacting with HRP-conjugated secondary antibody. The source and dilution of the primary antibodies were listed below.
###end p 72
###begin p 73
###xml 648 651 637 640 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 0 4 <span type="species:ncbi:9925">Goat</span>
###xml 33 39 <span type="species:ncbi:9986">rabbit</span>
###xml 58 62 <span type="species:ncbi:9925">goat</span>
###xml 83 89 <span type="species:ncbi:9986">rabbit</span>
###xml 121 126 <span type="species:ncbi:10090">mouse</span>
###xml 150 156 <span type="species:ncbi:9986">rabbit</span>
###xml 211 217 <span type="species:ncbi:9986">Rabbit</span>
###xml 246 252 <span type="species:ncbi:9986">rabbit</span>
###xml 280 286 <span type="species:ncbi:9986">rabbit</span>
###xml 315 321 <span type="species:ncbi:9986">rabbit</span>
###xml 404 409 <span type="species:ncbi:10090">mouse</span>
###xml 450 455 <span type="species:ncbi:10090">mouse</span>
###xml 502 507 <span type="species:ncbi:10090">mouse</span>
###xml 528 531 <span type="species:ncbi:9685">Cat</span>
###xml 560 565 <span type="species:ncbi:10090">mouse</span>
###xml 634 639 <span type="species:ncbi:10090">mouse</span>
Goat anti-GRP78 (C-20) (1:1000), rabbit anti-HA (1:1000), goat anti-PERK (1:1000), rabbit anti-ATF4 (1:1000), monoclonal mouse anti-CHOP (1:2000) and rabbit anti-ATF6 (1:1000) are from Santa Cruz Biotechnology. Rabbit anti-phospho-PERK (1:1000), rabbit anti-p-eIF2alpha (1:1000), rabbit anti-eIF2alpha (1:1000) and rabbit anti-cleaved caspase-3 (1:2000) are from Cell Signaling Biotechnology. Monoclonal mouse anti-beta-actin (1:5000) and monoclonal mouse anti-FLAG (1:5000) are from Sigma. Monoclonal mouse anti-GRP78 (1:2000, Cat. No. 610978) and monoclonal mouse anti-caspase-7 antibody (1:4000) are from BD Pharmingen. Monoclonal mouse anti-P58IPK is a gift from M.G. Katze (University of Washington).
###end p 73
###begin title 74
Confocal immunofluorescence microscopy
###end title 74
###begin p 75
###xml 174 178 174 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Parker1">[70]</xref>
The cells were fixed with 4% paraformaldehyde at room temperature for 10 minutes and washed twice with PBS. Immunofluorescence staining was performed as previously described [70]. The primary antibodies used are anti-HA polyclonal antibody and anti-GRP78 (H-129) antibody (1:500, Santa Cruz Biotechnology), followed by FITC-conjugated secondary antibodies (Vector Labs). The cells were mounted in Vectashield mounting medium (Vector Labs) and visualized on a Perkin-Elmer/Zeiss confocal microscope.
###end p 75
###begin title 76
Co-immunoprecipitation assay
###end title 76
###begin p 77
###xml 87 91 87 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006868-Fu1">[14]</xref>
The protocol for co-immunoprecipitation with the anti-FLAG antibody has been described [14].
###end p 77
###begin title 78
Soft agar colongenic survival assay
###end title 78
###begin p 79
A 0.3% soft agar solution was prepared by adding one volume of autoclaved 1.5% low melting temperature agarose to four volume of RPMI 1640 medium. HL-60 cells were mixed with the soft agar solution at a density of 300 cells/well in 6-well plates. The plating was performed in triplicate. Ten days later, the colonies with more than 50 cells were counted under inverted microscope. The survival fraction was normalized by dividing the number of surviving colonies of treated groups by that of untreated control groups.
###end p 79
###begin title 80
Supporting Information
###end title 80
###begin p 81
Supporting information and figure legends
###end p 81
###begin p 82
(0.05 MB DOC)
###end p 82
###begin p 83
Click here for additional data file.
###end p 83
###begin p 84
###xml 107 112 <span type="species:ncbi:10090">mouse</span>
###xml 509 514 <span type="species:ncbi:9606">human</span>
###xml 519 524 <span type="species:ncbi:10090">mouse</span>
###xml 583 588 <span type="species:ncbi:9606">human</span>
###xml 593 598 <span type="species:ncbi:10090">mouse</span>
###xml 709 714 <span type="species:ncbi:10090">mouse</span>
Discovery of the Alternative Transcript of Grp78. (A) Schematic representation of the intron 1 splicing in mouse Grp78. Arrows labeled as p1 and p2a indicate the primers used in RT-PCR. (B) RT-PCR was performed with cDNA samples from Tg-treated or non-treated NIH3T3 cells by using the primer set p1p2a. To assess the genomic contamination, PCR with the total RNA samples used for reverse transcription was performed. The gel image is shown with inverted background. (C) Alignment of the intron 1 sequence of human and mouse Grp78va. Arrows indicate the suboptimal splicing sites in human and mouse Grp78va. (D) Alignment of the primer p2a flanking sequence and the junction sequence of intron 1 and exon2 in mouse Grp78.
###end p 84
###begin p 85
(0.50 MB TIF)
###end p 85
###begin p 86
Click here for additional data file.
###end p 86
###begin p 87
###xml 340 349 340 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006868-g001">Figure 1A</xref>
###xml 303 308 <span type="species:ncbi:9606">human</span>
Induction of Grp78va Transcript by Tunicamycin and L-azetidine 2-carboxylic Acid. HeLa cells were either non-treated (-) or treated with 1.5 ug/ml tunicamycin (Tun) or 5 mM L-azetidine 2-carboxylic acid (AzC) for 16 h. Total RNA was subjected to RT-PCR with the specific primers (p1/3 and p4/5) for the human homologue of mGrp78va shown in Figure 1A. b-actin levels served as control.
###end p 87
###begin p 88
(0.18 MB TIF)
###end p 88
###begin p 89
Click here for additional data file.
###end p 89
###begin p 90
###xml 189 210 189 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
###xml 69 74 <span type="species:ncbi:9606">Human</span>
###xml 380 385 <span type="species:ncbi:9606">human</span>
Bioinformatic Analysis of Intron 1 Retention Alternative Splicing of Human Grp78 by Using a Microarray Database. Analysis of the microarray data was described in the Supporting Information Materials and Methods. The values of X-axis show the difference between the intensities of exon 1/2 and exon 2/3 probes in each tissue sample and the numbers plotted vertically correspond to human tissues or cancer cell lines included in the microarray database.
###end p 90
###begin p 91
(0.65 MB TIF)
###end p 91
###begin p 92
Click here for additional data file.
###end p 92
###begin p 93
Detection of GRP78 but not GRP78va by an Anti-N Terminus GRP78 Antibody. HeLa cells were transiently transfected with pcDNA3 (lane 1) or pcDNA/GRP78va-sm (lane 2) for 48 h. The cell lysates were analyzed by Western blots. Left panel shows immunoblot with anti-N-terminus GRP78 antibody (N-20 from Santa Cruz Biotechnology); right panel shows immunoblot with anti-C-terminus GRP78 antibody (C 20 from Santa Cruz Biotechnology). In the left panel, the asterisk (*) denotes a non-specific protein band that immunoreacts with the N-20 antibody.
###end p 93
###begin p 94
(0.23 MB TIF)
###end p 94
###begin p 95
Click here for additional data file.
###end p 95
###begin p 96
GRP78va is the Protein Product of the Grp78va Transcript. (A) Schematic diagram of Grp78va and canonical Grp78 mRNA showing the target (red arrow) of Grp78va-specific siRNA (siGrp78va) in intron 1 retained in Grp78va mRNA. (B) HeLa cells were transfected with siCtrl or siGrp78va for 72 h. The Grp78va and total Grp78 mRNA levels were evaluated by quantitative real-time PCR. The results were summarized and plotted with standard deviations. (C) HeLa cells were transfected with siCtrl or siGrp78va for 72 h. Endogenous GRP78va and canonical GRP78 were detected by Western blots using anti-GRP78 monoclonal antibody with b-actin as loading control. For the abundant canonical GRP78, a light exposure is shown. (D) The experiments described in (C) were repeated three times. The GRP78va and GRP78 protein levels were quantitated and normalized to b-actin level. The results were summarized and plotted with standard deviations.
###end p 96
###begin p 97
(0.53 MB TIF)
###end p 97
###begin p 98
Click here for additional data file.
###end p 98
###begin p 99
Dual Localization of P58IPK in the ER and the Cytosol. HeLa cells transiently transfected with pcDNA/P58IPK-FLAG were fixed in methanol and stained with anti-FLAG monoclonal antibody (1:1000, Sigma) for detection of P58IPK (red), followed by anti-PDI polyclonal antibody (1:500, Santa Cruz Biotechnology) as the ER marker (green), and then DAPI to indicate the nucleus (blue). The cells were subjected to confocal microscopy. The individual images and the merged image are shown.
###end p 99
###begin p 100
(2.10 MB TIF)
###end p 100
###begin p 101
Click here for additional data file.
###end p 101
###begin p 102
###xml 249 270 249 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">Materials and Methods</xref>
GRP78va Promotes HeLa Cell Survival During ER Stress. (A) HeLa cells transfected with siCtrl or siGrp78va were exposed to Tg (1 uM) for the indicated hours and then re-plated in fresh medium for colongenic survival assay (see Supporting Information Materials and Methods). After 10-14 days, the colonies were counted and the survival fractions were plotted against the time of treatment as indicated. (B) HeLa cells stably overexpressing GRP78va (Grp78va) or control cells (vector) were treated with Tg (1 uM) for the indicated hours and then subjected to colongenic survival assay.
###end p 102
###begin p 103
(0.32 MB TIF)
###end p 103
###begin p 104
Click here for additional data file.
###end p 104
###begin p 105
###xml 842 847 <span type="species:ncbi:9606">human</span>
###xml 852 857 <span type="species:ncbi:10090">mouse</span>
###xml 871 876 <span type="species:ncbi:9606">human</span>
###xml 905 910 <span type="species:ncbi:10090">mouse</span>
###xml 946 951 <span type="species:ncbi:9606">human</span>
GRP78va is Stabilized by Proteasome Inhibitor (A) Proteasome inhibitor stabilizes overexpressed HA-GRP78va. 293T cells transiently transfected with pcDNA/HA-Grp78va were either non-treated (-) or treated (+) with MG115 (2 h) or Tg (16 h) as indicated and subjected to Western blots. The HA-GRP78va levels normalized to b-actin are indicated below. (B) GRP78va has a short half-life. 293T cells were transfected with pcDNA/HA-GRP78va and after 24 h, the cells were seeded onto the 6-well plates. Next day, the cells were treated with cycloheximide (CHX) for the time (in hours) indicated on top. The cell lysates were collected and analyzed by Western blot using antibodies against GRP78 (C-20) and b-actin. The positions of GRP78 and HA-GRP78va are indicated. The HA-GRP78va levels normalized to b-actin are indicated below. (C) Alignment of human and mouse GRP78va with human GRP78 protein sequence. The mouse GRP78va amino acids divergent from human GRP78 and GRP78va are highlighted in red. The PEST-rich region is boxed, and the enrichment of proline (P), glutamic acid (E), serine (S), and threonine (T) residues are bolded.
###end p 105
###begin p 106
(0.67 MB TIF)
###end p 106
###begin p 107
Click here for additional data file.
###end p 107
###begin p 108
Summary of alternative splicing by intron retention from Grp78va gene.
###end p 108
###begin p 109
(0.53 MB TIF)
###end p 109
###begin p 110
Click here for additional data file.
###end p 110
###begin p 111
###xml 215 218 215 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IPK</sup>
###xml 82 89 <span type="species:ncbi:9606">patient</span>
We thank Allen Yang and Jiayi Jiang for providing and advising us on the leukemia patient samples; Jian Xu and Qi Wang for assistance in the bioinformatic analysis and quantitative PCR; and Michael Katze for the P58IPK antibody. We thank Ernesto Barron and David Hinton of the USC/Norris Comprehensive Cancer Center Cell and Tissue Imaging Core Facility for assistance with the confocal microscopy. We thank Shengzhan Luo for his initial observations and advice, Yong Fu for assistance and other Lee laboratory members, for helpful discussions.
###end p 111
###begin title 112
References
###end title 112
###begin article-title 113
A trip to the ER: coping with stress.
###end article-title 113
###begin article-title 114
Signal integration in the endoplasmic reticulum unfolded protein response.
###end article-title 114
###begin article-title 115
The glucose-regulated proteins: stress induction and clinical applications.
###end article-title 115
###begin article-title 116
The ER function BiP is a master regulator of ER function.
###end article-title 116
###begin article-title 117
Stress induction of GRP78/BiP and its role in cancer.
###end article-title 117
###begin article-title 118
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human gene encoding the 78,000-dalton glucose-regulated protein and its pseudogene: structure, conservation, and regulation.
###end article-title 118
###begin article-title 119
The ER chaperone and signaling regulator GRP78/BiP as a monitor of endoplasmic reticulum stress.
###end article-title 119
###begin article-title 120
Characterization of an ERAD pathway for nonglycosylated BiP substrates, which require Herp.
###end article-title 120
###begin article-title 121
ERdj5 is required as a disulfide reductase for degradation of misfolded proteins in the ER.
###end article-title 121
###begin article-title 122
Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response.
###end article-title 122
###begin article-title 123
###xml 25 30 <span type="species:ncbi:9606">human</span>
The crystal structure of human IRE1 luminal domain reveals a conserved dimerization interface required for activation of the unfolded protein response.
###end article-title 123
###begin article-title 124
Coupling endoplasmic reticulum stress to the cell death program: role of the ER chaperone GRP78.
###end article-title 124
###begin article-title 125
Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis induced by topoisomerase inhibitors: role of ATP binding site in suppression of caspase-7 activation.
###end article-title 125
###begin article-title 126
###xml 58 63 <span type="species:ncbi:9606">human</span>
GRP78/BiP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen-starvation induced apoptosis.
###end article-title 126
###begin article-title 127
GRP78 induction in cancer: therapeutic and prognostic implications.
###end article-title 127
###begin article-title 128
###xml 43 48 <span type="species:ncbi:9606">human</span>
ER chaperones in mammalian development and human diseases.
###end article-title 128
###begin article-title 129
Role of the unfolded protein response regulator GRP78/BiP in development, cancer and neurological disorders.
###end article-title 129
###begin article-title 130
Adaptation to ER stress is mediated by differential stabilities of pro-survival and pro-apoptotic mRNAs and proteins.
###end article-title 130
###begin article-title 131
IRE1 signaling affects cell fate during the unfolded protein response.
###end article-title 131
###begin article-title 132
Purification and partial characterization of a cellular inhibitor of the interferon-induced protein kinase of Mr 68,000 from influenza virus-infected cells.
###end article-title 132
###begin article-title 133
P58IPK, a novel endoplasmic reticulum stress-inducible protein and potential negative regulator of eIF2alpha signaling.
###end article-title 133
###begin article-title 134
Cotranslocational degradation protects the stressed endoplasmic reticulum from protein overload.
###end article-title 134
###begin article-title 135
The role of p58IPK in protecting the stressed endoplasmic reticulum.
###end article-title 135
###begin article-title 136
Regulation of apoptosis by alternative pre-mRNA splicing.
###end article-title 136
###begin article-title 137
Alternative splicing: an emerging topic in molecular and clinical oncology.
###end article-title 137
###begin article-title 138
How did alternative splicing evolve?
###end article-title 138
###begin article-title 139
###xml 54 59 <span type="species:ncbi:9606">human</span>
Sequence features responsible for intron retention in human.
###end article-title 139
###begin article-title 140
###xml 22 27 <span type="species:ncbi:9606">human</span>
Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays.
###end article-title 140
###begin article-title 141
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
In vitro dissociation of BiP-peptide complexes requires a conformational change in BiP after ATP binding but does not require ATP hydrolysis.
###end article-title 141
###begin article-title 142
Control of PERK eIF2alpha kinase activity by the endoplasmic reticulum stress-induced molecular chaperone P58IPK.
###end article-title 142
###begin article-title 143
Regulated association of misfolded endoplasmic reticulum lumenal proteins with P58/DNAJc3.
###end article-title 143
###begin article-title 144
ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth.
###end article-title 144
###begin article-title 145
Perk-dependent translational regulation promotes tumor cell adaptation and angiogenesis in response to hypoxic stress.
###end article-title 145
###begin article-title 146
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
In vivo interrogation of the molecular display of atherosclerotic lesion surfaces.
###end article-title 146
###begin article-title 147
Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands.
###end article-title 147
###begin article-title 148
Activation and cross-talk between Akt, NF-kappaB, and unfolded protein response signaling in 1-LN prostate cancer cells consequent to ligation of cell surface-associated GRP78.
###end article-title 148
###begin article-title 149
Identification of proteins associating with glycosylphosphatidylinositol- anchored T-cadherin on the surface of vascular endothelial cells: role for Grp78/BiP in T-cadherin-dependent cell survival.
###end article-title 149
###begin article-title 150
A new tumor-specific variant of GRP78 as target for antibody-based therapy.
###end article-title 150
###begin article-title 151
Mechanistic studies of a peptidic GRP78 ligand for cancer cell-specific drug delivery.
###end article-title 151
###begin article-title 152
GRP78 and Cripto form a complex at the cell surface and collaborate to inhibit transforming growth factor beta signaling and enhance cell growth.
###end article-title 152
###begin article-title 153
Hypoxic inhibition of nonsense-mediated RNA decay regulates gene expression and the integrated stress response.
###end article-title 153
###begin article-title 154
PEST sequences and regulation by proteolysis.
###end article-title 154
###begin article-title 155
Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis.
###end article-title 155
###begin article-title 156
Mutations within the nucleotide binding site of immunoglobulin-binding protein inhibit ATPase activity and interfere with release of immunoglobulin heavy chain.
###end article-title 156
###begin article-title 157
The efficiency of protein compartmentalization into the secretory pathway.
###end article-title 157
###begin article-title 158
Retrotranslocation of the chaperone calreticulin from the endoplasmic reticulum lumen to the cytosol.
###end article-title 158
###begin article-title 159
###xml 17 34 <span type="species:ncbi:10407">hepatitis B virus</span>
Targeting of the hepatitis B virus precore protein to the endoplasmic reticulum membrane: after signal peptide cleavage translocation can be aborted and the product released into the cytoplasm.
###end article-title 159
###begin article-title 160
###xml 4 21 <span type="species:ncbi:10407">hepatitis B virus</span>
The hepatitis B virus precore protein is retrotransported from endoplasmic reticulum (ER) to cytosol through the ER-associated degradation pathway.
###end article-title 160
###begin article-title 161
The cellular protein P58IPK regulates influenza virus mRNA translation and replication through a PKR-mediated mechanism.
###end article-title 161
###begin article-title 162
The diversity of the DnaJ/Hsp40 family, the crucial partners for Hsp70 chaperones.
###end article-title 162
###begin article-title 163
Mechanisms for regulation of Hsp70 function by Hsp40.
###end article-title 163
###begin article-title 164
Identification and characterization of a novel endoplasmic reticulum (ER) DnaJ homologue, which stimulates ATPase activity of BiP in vitro and is induced by ER stress.
###end article-title 164
###begin article-title 165
ERdj5, an endoplasmic reticulum (ER)-resident protein containing DnaJ and thioredoxin domains, is expressed in secretory cells or following ER stress.
###end article-title 165
###begin article-title 166
MDG1/ERdj4, an ER-resident DnaJ family member, suppresses cell death induced by ER stress.
###end article-title 166
###begin article-title 167
Functional coupling of p38-induced up-regulation of BiP and activation of RNA-dependent protein kinase-like endoplasmic reticulum kinase to drug resistance of dormant carcinoma cells.
###end article-title 167
###begin article-title 168
The unfolded protein response regulator GRP78/BiP is required for endoplasmic reticulum integrity and stress-induced autophagy in mammalian cells.
###end article-title 168
###begin article-title 169
###xml 45 49 <span type="species:ncbi:10090">mice</span>
Pancreatic beta-cell failure and diabetes in mice with a deletion mutation of the endoplasmic reticulum molecular chaperone gene P58IPK.
###end article-title 169
###begin article-title 170
###xml 63 68 <span type="species:ncbi:9606">human</span>
p210BCR/ABL-induced alteration of pre-mRNA splicing in primary human CD34+ hematopoietic progenitor cells.
###end article-title 170
###begin article-title 171
###xml 94 100 <span type="species:ncbi:10090">murine</span>
Spi-1/PU.1 but not Fli-1 inhibits erythroid-specific alternative splicing of 4.1R pre-mRNA in murine erythroleukemia cells.
###end article-title 171
###begin article-title 172
The fusion oncoprotein PML-RARalpha induces endoplasmic reticulum (ER)-associated degradation of N-CoR and ER stress.
###end article-title 172
###begin article-title 173
Inhibition of Ca2+ influx is required for mitochondrial reactive oxygen species-induced endoplasmic reticulum Ca2+ depletion and cell death in leukemia cells.
###end article-title 173
###begin article-title 174
Endoplasmic reticulum stress initiates apoptotic death induced by STI571 inhibition of p210 bcr-abl tyrosine kinase.
###end article-title 174
###begin article-title 175
Proteomic analysis of hematopoietic stem cell-like fractions in leukemic disorders.
###end article-title 175
###begin article-title 176
Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival and tumor angiogenesis in transgene-induced mammary tumor development.
###end article-title 176
###begin article-title 177
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
Pten null prostate tumorigenesis and AKT activation are blocked by targeted knockout of the stress response chaperone GRP78/BiP in prostate epithelium.
###end article-title 177
###begin article-title 178
The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas.
###end article-title 178
###begin article-title 179
Stress chaperone GRP78/BiP confers chemoresistance to tumor-associated endothelial cells.
###end article-title 179
###begin article-title 180
Pyrvinium targets the unfolded protein response to hypoglycemia and its anti-tumor activity is enhanced by combination therapy.
###end article-title 180
###begin article-title 181
Transcriptional induction of GRP78/BiP by histone deacetylase inhibitors and resistance to histone deacetylase inhibitor-induced apoptosis.
###end article-title 181
###begin article-title 182
Identification of TFII-I as the endoplasmic reticulum stress response element binding factor ERSF: its autoregulation by stress and interaction with ATF6.
###end article-title 182
###begin p 183
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 183
###begin p 184
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was funded by National Institutes of Health grants R01 CA027607 and R01 CA111700 to ASL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 184

